CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy

Nephron. Clinical Practice
K YoshimotoHitoshi Yokoyama

Abstract

A considerable diversity of prognosis is seen with idiopathic membranous nephropathy (IMN). The initial factors affecting long-term outcome remain unclear. We studied retrospectively 30 patients with IMN who had been followed up for at least 5 years, or until end-stage renal failure (ESRF). We analyzed the prognostic factors of ESRF in the first renal biopsies; these factors included presence of tubulointerstitial lesions and foam cells, as well as expression of CD68, monocyte chemoattractant protein-1 (MCP-1), its cognate receptor chemokine receptor 2 (CCR2) and alpha-smooth muscle actin. The patients who developed ESRF showed higher percentages of glomerular segmental sclerosis, interstitial MCP-1 expression, CCR2- or CD68-positive monocyte/macrophages and foam cells in the interstitium, and these proved on multivariate analysis to be independent risk factors for ESRF. Finally, ESRF was characterized by the presence of ten interstitial CD68-positive cells per visual field at 200x magnification (hazard ratio 4.096, CI 1.271-15.029, p < 0.001). Our results suggested that an interstitial infiltration of CD68-positive cells accompanied by MCP-1/CCR2 expression is the most significant indicator of ESRF in IMN.

Citations

Dec 6, 2011·QJM : Monthly Journal of the Association of Physicians·B Conway, J Hughes
Jul 3, 2009·American Journal of Physiology. Renal Physiology·Nader G AbrahamGeorge Drummond
Feb 19, 2014·Expert Reviews in Molecular Medicine·Juan Antonio MorenoJesús Egido
Jul 17, 2012·Expert Opinion on Therapeutic Targets·Juan Antonio MorenoJesús Egido
Mar 8, 2014·Advances in Chronic Kidney Disease·Yasar Caliskan, Krzysztof Kiryluk
Mar 28, 2008·Kidney International·S SegererD Schlöndorff
Jul 14, 2010·Seminars in Nephrology·Jeremy S Duffield
Jul 14, 2010·Seminars in Nephrology·Madeleine A VernonJeremy Hughes
Dec 2, 2008·Clinical and Experimental Immunology·L M McIntoshJ R McDonald
Aug 20, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Min Jeong Kim, Frederick W K Tam
Oct 1, 2014·Nature Reviews. Nephrology·Natasha M RogersJeremy Hughes
Sep 12, 2017·Biomarkers in Medicine·Shiva Kalantari, Mohsen Nafar
Sep 14, 2006·American Journal of Physiology. Renal Physiology·Narayana S MuraliKarl A Nath
Jul 25, 2021·International Journal of Molecular Sciences·Zoran V PopovicStefan Porubsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.